% | $
Quotes you view appear here for quick access.

Antares Pharma Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • snowshovel70 snowshovel70 Feb 24, 2012 3:04 PM Flag

    Litigation thoughts.

    This just my opinion but if they DONT have a pen ready for marketing or extremely close then they are being very short sighted. Another reason it would be smart to have two pens or perhaps more with minor deviations. What is the compromise is fine you can make generic pens BUT the design has to be IDENTICAL to the Pfizer one? Or if they dont make that stipulation and AIS has a better design BAM we get to show the market how we can improve on the pen and do better than big bad Pfizer :)

    SortNewest  |  Oldest  |  Most Replied Expand all replies